FdaApplication
NDA 020943
Identifiers
- fda_app_no: NDA020943
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1998-11-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VERELAN PM | VERAPAMIL HYDROCHLORIDE | 300MG | CAPSULE, EXTENDED RELEASE;ORAL |
| VERELAN PM | VERAPAMIL HYDROCHLORIDE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
| VERELAN PM | VERAPAMIL HYDROCHLORIDE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL |
3 products